Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Oncology

• Publication date

  2009-09-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1200/JCO.2009.22.8858PMID 19704056PMCID PMC2754907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

  2010cited by this paper
• Gastrosplenic fistula from Hodgkin's lymphoma.

  2009cited by this paper
• Stage-specific prognostic value of molecular markers in colon cancer: Results of the translational study on the PETACC 3-EORTC 40993-SAKK 60-00 trial.

  2009cited by this paper
• PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.

  2009cited by this paper
• JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.

  2009cited by this paper
• Genomic and epigenetic instability in colorectal cancer pathogenesis.

  2008cited by this paper
• Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.

  2008cited by this paper
• A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.

  2008cited by this paper
• Individualized prediction of colon cancer recurrence using a nomogram.

  2008cited by this paper
• Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.

  2008cited by this paper
• Cohort study of fatty acid synthase expression and patient survival in colon cancer.

  2008cited by this paper
• Molecular classification and correlates in colorectal cancer.

  2008cited by this paper
• LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer

  2008cited by this paper
• CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

  2008cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.

  2008cited by this paper
• Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

  2008cited by this paper
• Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

  2007cited by this paper
• Classification of colorectal cancer based on correlation of clinical, morphological and molecular features

  2007cited by this paper
• The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.

  2007cited by this paper
• Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.

  2007cited by this paper
• Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP

  2007cited by this paper
• Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

  2007cited by this paper
• Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.

  2006cited by this paper
• CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

  2006cited by this paper
• CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies

  2006cited by this paper
• Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

  2006cited by this paper
• CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.

  2006cited by this paper
• Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.

  2006cited by this paper
• Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component

  2006cited by this paper
• Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage.

  2006cited by this paper
• Systematic review of microsatellite instability and colorectal cancer prognosis.

  2005cited by this paper
• Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

  2005cited by this paper
• The Nurses' Health Study: lifestyle and health among women

  2005cited by this paper
• A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.

  2005cited by this paper
• The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer

  2005cited by this paper
• Association Between Recurrence of Sporadic Colorectal Cancer, High Level of Microsatellite Instability, and Loss of Heterozygosity at Chromosome 18q

  2004cited by this paper
• Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus.

  2003cited by this paper
• Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.

  2003cited by this paper
• DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study.

  2002cited by this paper
• Counting alleles to predict recurrence of early-stage colorectal cancers.

  2002cited by this paper
• Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

  2001cited by this paper
• Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.

  1999cited by this paper
• Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers

  1999cited by this paper
• Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.

  1998cited by this paper
• Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.

  1998cited by this paper
• Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.

  1998cited by this paper
• Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers

  1996cited by this paper
• Allelic loss of chromosome 18q and prognosis in colorectal cancer.

  1994cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Flexible regression models with cubic splines.

  1989cited by this paper

• SMAD4 loss drives cancer chromosomal instability through transcription-replication conflict-induced replication stress

  2025cites this paper
• Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments

  2023cites this paper
• Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies

  2023cites this paper
• A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma

  2022cites this paper
• Predictive value of chromosome 18q11.2‐q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III‐trial AGITG‐MAX

  2022cites this paper
• Metabolic changes in colorectal carcinomas are key factors for the early detection of neoplastic change

  2021cites this paper
• Labordiagnostik bei gastrointestinalen Tumoren

  2020cites this paper
• Pathways of Colorectal Carcinogenesis.

  2020cites this paper
• Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies

  2020cites this paper
• Labordiagnostik bei gastrointestinalen Tumoren

  2020cites this paper
• Labordiagnostik/Tumormarker: Was ist sinnvoll/effektiv, was wird kommen?

  2020cites this paper
• Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements

  2020cites this paper
• CMAR_A_251223 9869..9882

  2020cites this paper
• Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer

  2019influential citation
• Biomarkers for Stratification in Colorectal Cancer: MicroRNAs

  2019cites this paper
• Functional Consequences and Clinical Significance of Tyrosine Kinase Inhibitors in Advanced Colorectal Cancer

  2018cites this paper
• Molecular Basis of Colorectal Cancer: Tumor Biology

  2018cites this paper
• Adjuvant Chemotherapy

  2018cites this paper
• THE FUNCTION OF ERBIN, A SCAFFOLD PROTEIN, AS A TUMOR SUPPRESSOR IN COLON CANCER

  2018cites this paper
• Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients

  2018cites this paper
• HER 2 NEU and KI67 expression as immunolocalisation in colorectal carcinoma

  2018cites this paper
• Role of Tyrosine Kinases in Gastrointestinal Malignancies

  2018influential citation
• The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy.

  2018cites this paper
• Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients

  2018cites this paper
• Clinical relevance of colorectal cancer molecular subtypes.

  2017cites this paper
• Current and future biomarkers in the treatment of colorectal cancer

  2017cites this paper
• Copy number variations in DCC/18q and ERBB2/17q are associated with disease‐free survival in microsatellite stable colon cancer

  2017cites this paper
• NDRG2 gene copy number is not altered in colorectal carcinoma

  2017cites this paper
• Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis

  2017cites this paper
• Genetic and epigenetic markers in colorectal cancer screening: recent advances

  2017cites this paper
• What Mutagenic Events Contribute to Human Cancer and Genetic Disease

  2017cites this paper
• Identification of novel therapeutic targets and tumor suppressor genes in colon cancer using genome-wide high‐throughput approaches

  2016cites this paper
• Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.

  2016cites this paper
• Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen

  2016cites this paper
• Title: Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumours as defined by high-density single nucleotide polymorphism (SNP) – arrays

  2016cites this paper
• 5-Fluorouracil mediated cell death signaling in colon carcinoma cells

  2016cites this paper
• Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy

  2015cites this paper
• Precision medicine in colorectal cancer

  2015cites this paper
• Biomarkers for personalized medicine in GI cancers.

  2015influential citation
• The Effects of miR‐20a on p21: Two Mechanisms Blocking Growth Arrest in TGF‐β‐Responsive Colon Carcinoma

  2015cites this paper
• Determination of Effective Factors on Survival of GI Cancers: Results of Five Years Follow up in Iranian Population

  2015cites this paper
• Neoplasia of the gastrointestinal tract

  2015cites this paper
• Environmental Epigenetics and Obesity: Evidences from Animal to Epidemiologic Studies

  2015cites this paper
• Microenvironmental Control of Metastatic Progression

  2015cites this paper
• Molecular Backgrounds of ERAP1 Downregulation in Cervical Carcinoma

  2015cites this paper
• BRAF V600E mutation in colorectal cancer is associated with right-sided tumours and iron deficiency anaemia.

  2015cites this paper
• Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.

  2014cites this paper
• Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.

  2014cites this paper
• Genetic and clinical prognostic markers for colorectal cancer

  2014cites this paper
• The role of tumor markers and biomarkers in colorectal cancer.

  2014cites this paper
• Aspects of Heredity, Prognosis and Tumour Markers

  2014cites this paper
• Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia

  2014cites this paper
• Mechanisms of obesity-induced gastrointestinal neoplasia.

  2014cites this paper
• Prognostic and predictive significance of MSI in stages II/III colon cancer.

  2014cites this paper
• Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review

  2014cites this paper
• COLORECTAL CANCER, NOVEL BIOMARKERS AND IMMUNOHISTOCHEMISTRY - AN OVERVIEW

  2014cites this paper
• Personalized Management of Colorectal Cancer

  2013cites this paper
• Biomarkers in precision therapy in colorectal cancer

  2013cites this paper
• Serrated colon polyps as precursors to colorectal cancer.

  2013cites this paper
• Title: Elevated Alcam Shedding in Colorectal Cancer Correlates with Poor Patient Outcome. Disclosure of Potential Conflicts of Interest Hansen Et Al. Page 2

  2013cites this paper
• Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease

  2013cites this paper
• Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?

  2013cites this paper
• Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

  2013cites this paper
• Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention

  2013cites this paper
• Adjuvant therapy of stage III colon cancer.

  2013cites this paper
• Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis

  2013cites this paper
• Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma.

  2013cites this paper
• Molecular Mechanisms of Colorectal Carcinogenesis

  2013cites this paper
• The role of tumour markers and biomarkers in colorectal cancer

  2013cites this paper
• Molecular markers in radically resected colorectal cancer: from prognosis to prediction

  2013cites this paper
• Copy-Number Alterations in the Colorectal Cancer Genome

  2013cites this paper
• Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer

  2013cites this paper
• Genomic and Epigenetic Instability in Colorectal Cancer

  2013cites this paper
• Predictive and Prognostic Biomarkers for Colorectal Cancer

  2013cites this paper
• in with

  2013cites this paper
• PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Serrated Colon Polyps as Precursors to Colorectal Cancer

  2013cites this paper
• Novel Prognostic Biomarkers in Colorectal Cancer

  2012cites this paper
• Gene signatures in colorectal cancer

  2012cites this paper
• Tumorigenesis and Neoplastic Progression Molecular Dissection of Premalignant Colorectal Lesions Reveals Early Onset of the CpG Island Methylator Phenotype

  2012cites this paper
• The Role of Infectious Agents in Colorectal Carcinogenesis

  2012influential citation
• Current trends in the chemotherapy of colorectal cancer.

  2012cites this paper
• Chromosomal Instability in BRAF Mutant, Microsatellite Stable Colorectal Cancers

  2012cites this paper
• Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers

  2012cites this paper
• Università degli Studi di Milano Scuola di Dottorato in Medicina Molecolare

  2012cites this paper
• Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.

  2012cites this paper
• Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer.

  2012cites this paper
• Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach.

  2012cites this paper
• Genetic alterations in colorectal cancer.

  2012cites this paper
• Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays

  2012cites this paper
• Molecular profiling for stage II colon cancer

  2012cites this paper
• Imaging , Diagnosis , Prognosis Speci fi c Mutations in KRAS Codons 12 and 13 , and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers

  2012cites this paper
• Transcriptome Profiling of the Cancer, Adjacent Non-Tumor and Distant Normal Tissues from a Colorectal Cancer Patient by Deep Sequencing

  2012cites this paper
• Oncogenic PIK3CA mutations in colorectal cancers and polyps

  2012cites this paper
• Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature.

  2012cites this paper
• STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers

  2011cites this paper
• Prognostic and Predictive Markers in Colorectal Cancer

  2011cites this paper
• Adjuvant Treatment and Predictors of Response in Colon Cancer

  2011cites this paper
• Biological Markers in Patients with Early-Stage Colon Cancer: Consensus and Controversies

  2011cites this paper
• Molecular testing of solid tumors.

  2011cites this paper
• Quantitative Approaches to Understanding Cancer Genomes.

  2011cites this paper